Nowak-Sliwinska, Patrycja
van Beijnum, Judy R.
Huijbers, Elisabeth J. M.
Gasull, Paula C.
Mans, Laurie
Bex, Axel
Griffioen, Arjan W.
Funding for this research was provided by:
EC | European Research Council (ERC-StG-2015-680209)
KWF Kankerbestrijding (VU2014-7234, VU2014-7234, VU 2012-548)
Article History
Received: 29 August 2018
Revised: 17 October 2018
Accepted: 24 October 2018
First Online: 18 December 2018
Availability of data and materials
: All the data generated or analysed in this study are included in the manuscript or the InternalRef removed.
: The study was performed in accordance with the Declaration of Helsinki. Animal experiments were approved by the Institutional Animal Care and Use Committee at the Roswell Park Cancer Institute and was in accordance with the National Research Council’s Guide for the Care and Use of Laboratory Animals, as described previously.<sup>34</sup> The RNA sequencing experiments on embryos and adult mice were approved by local animal experimental committee of VU University (AngL13-01A1). The use of human tissues was approved by the local ethical review committee of the Netherlands Cancer Institute (PI. Dr. A. Bex). The result of the clinical study was published previously.<sup>24</sup>
: The authors declare no competing interests.